2010 Metabolic Syndrome

download 2010 Metabolic Syndrome

of 48

Transcript of 2010 Metabolic Syndrome

  • 7/31/2019 2010 Metabolic Syndrome

    1/48

    METABOLIC SYNDROME

    Nature, Nurture, NutritionGenomics, Proteomics,

    Metabolomics

  • 7/31/2019 2010 Metabolic Syndrome

    2/48

    Janice Werbinski, M.D., FACOG

    Gynecologist -Borgess Womens Health

    Former Medical Director -BMH Womens Center

    Associate Clinical Professor - MSU / CHM

    Author, Curriculum, Womens Health Track,

    Internal Medicine Residency, MSU/KCMS

    Founding President, ACWHPConsultant/Metabolic Syndrome Program

    Borgess Integrative Medicine

  • 7/31/2019 2010 Metabolic Syndrome

    3/48

    CLASSIC DEFINITIONSyndrome X (Dr. G. Reaven)

    High Blood Pressure (>130/85)

    High Blood Fats (Triglyceride) (>150)

    Low HDL (Good) Cholesterol (110 mg/dl)

    Increased Waist to Hip Ratio (>35 waist)

    Central Obesity-Inability to Lose Weight

    Family History of DM, HTN, CVD,Obesity

  • 7/31/2019 2010 Metabolic Syndrome

    4/48

    FUNCTIONAL MEDICINEDEFINITION

    Metabolic Syndrome

    An age-related functional disorder of

    glucose metabolism, mediated byaltered genetic expression at the cell

    membrane level, and manifested under

    particular environmental conditions.

    -Dan Lukaczer, ND

    Institute for Functional Medicine

  • 7/31/2019 2010 Metabolic Syndrome

    5/48

    Alternative Labels

    Syndrome X

    Metabolic SyndromeInsulin Resistance

    Pre-Diabetes

    Glucose Intolerance

  • 7/31/2019 2010 Metabolic Syndrome

    6/48

    INCIDENCE

    Up to 25% of Americans (47,000,000 in US)

    50% May not be Obese

    Increasing in Children and AdolescentsIncreasing in Industrialized Nations

    Very Close Association with:

    -Diabetes-Cardiovascular Disease

    -PCOS

    -Preeclampsia / Eclampsia

  • 7/31/2019 2010 Metabolic Syndrome

    7/48

    LABORATORY

    PARAMETERSFasting Glucose & Insulin

    2 hour Glucose & Insulin after 75gm glucola

    Lipid panel

    Homocysteine

    Thyroid panelCRP

    Euglycemic Clamp Studies (Research)

  • 7/31/2019 2010 Metabolic Syndrome

    8/48

    CAUSES

    1. GENETIC PREDISPOSITION (Genomics)

    2. STANDARD AMERICAN DIET (SAD) Processed Foods, Preservatives, Additives

    Low-and No-Fat Foods (High Carb) The Food Pyramid (High Carb)

    Trans- and Saturated Fats

    Low in Essential Nutrients and Fiber

    High Fructose Corn Syrup and Soda3. SEDENTARY LIFESTYLE

    4. GLUTEN AND DAIRY INTOLERANCE common

  • 7/31/2019 2010 Metabolic Syndrome

    9/48

    Does Nutrigenomics Play a Role?

  • 7/31/2019 2010 Metabolic Syndrome

    10/48

  • 7/31/2019 2010 Metabolic Syndrome

    11/48

    RESULTING SYNDROMES

    Classic presentation

    CAD

    CVA

    HyperlipidemiaHypertension

    DM

    Obesity

    Cancer

    PCOS

  • 7/31/2019 2010 Metabolic Syndrome

    12/48

  • 7/31/2019 2010 Metabolic Syndrome

    13/48

    CLASSIC APPROACH(KNEE-JERK)

    Missing the Forest for theTrees

  • 7/31/2019 2010 Metabolic Syndrome

    14/48

    Traditional Allopathic Approach

    Abnormal Parameter, Symptom, or LaboratoryBlood Values: GTT, or 2 hr Postprandial Glucose

    LDL Cholesterol

    Blood Pressure

    High BMI

    Mood Disorders

    GERD

    Fibromyalgia/ Chronic Fatigue Syndrome

    Signs of PCOS

    IBS

  • 7/31/2019 2010 Metabolic Syndrome

    15/48

    Knee-Jerk Reaction

    Diabetic Meds

    Antihypertensives

    Statins

    AnalgesicsOCs/Progestins

    Antidepressants

    Proton pump inhibitors

    Anorexics

    Bariatric Surgery

  • 7/31/2019 2010 Metabolic Syndrome

    16/48

    WHY TRADITIONAL

    APPROACH FAILSPatient has intense CHO cravings diet &medications alone do not lessen the cravings

    Patients worry about the multiple symptoms, thinking

    their body is becoming alien - need emotional support& education of this multidimensional condition

    Medications are prescribed to treat a prevalentsymptom or disease, not the global assimilation ofsymptoms

    Poly-pharmacy increases drug interaction, cost, sideeffects, & non-compliance

    Patients ask for a holistic model due to multiplesymptoms

    Patients want to be FUNCTIONAL again

  • 7/31/2019 2010 Metabolic Syndrome

    17/48

  • 7/31/2019 2010 Metabolic Syndrome

    18/48

    NUTRITIONAL APPROACH

    Kalamazoo Heart Center of

    Excellence:Metabolic Syndrome

    Program

  • 7/31/2019 2010 Metabolic Syndrome

    19/48

    THE CASE FOR NUTRITIONALTHERAPIES

    This disorder does not result from a lack of

    prescription drugs

    There is no magic bullet

    Many end up taking 4 or more drugs then

    dealing with an array of side effects

    Drugs merely treat a symptom or lab valuewhile allowing the underlying disease

    process to continue

  • 7/31/2019 2010 Metabolic Syndrome

    20/48

    TREATMENT PLANOnce diagnosis is made:

    Assess any medical problems

    Psychophysiological assessment: meet the patient in

    theirmoment with all of their symptomsSet up Primary and Secondary goals together withthe patient

    Nutritional Supplement Recommendations

    40-30-30 Macronutrient PlanLifestyle Modification Discussion

    F/U at 3 wks, 8 wks, 3 mos, 6 mos, 9 mos, 12 mos

    Group Classes for Health Education

  • 7/31/2019 2010 Metabolic Syndrome

    21/48

    PROGRAM GOALS

    Appropriate Calories to Ideal Weight

    Increase Omega-3 Oils

    Increase MonoUnsaturated (Mediterranean) Fat

    Low Saturated and Trans Fatty Acids

    Low Glycemic Index Foods

    High Fiber

    Low simple CHO (increase complex CHO)

    Moderate Protein

  • 7/31/2019 2010 Metabolic Syndrome

    22/48

  • 7/31/2019 2010 Metabolic Syndrome

    23/48

    NUTRICEUTICAL

    TREATMENTDIET IN GENERAL:

    Mediterranean

    30% Protein

    30% Good Fats (monounsaturated)

    40% Low Glycemic Index Carbs

    Soy

    High in Soluble Fiber

    Micronutrients

  • 7/31/2019 2010 Metabolic Syndrome

    24/48

    NUTRICEUTICAL

    MODE OF ACTIONOMEGA - 3 FATS (EPA/DHA)-Cell Wall and

    Receptor Function

    a LIPOIC ACID -Mimics InsulinMG -Needed for release of Insulin

    CHROMIUM -Increases function of insulin

    VANADIUM -Mimics insulin (>100mg toxic)gamma LINOLEIC ACID-Restores insulin

    function. Restores nerve function

    FIBER -Slows Glu absorption in GI Tract

  • 7/31/2019 2010 Metabolic Syndrome

    25/48

    MODE OF ACTION

    Pharmaceutical vs. Nutriceutical

    ENHANCEDINSULINSECRETION

    SLOWED

    GLUCOSE

    ABSORPTION

    REDUCEDGLUCOSEPRODUCTION

    PERIPHERAL

    GLUCOSEDISPOSAL

    IMPROVEDRECEPTORFUNCTION

    PHARMA

    CEUTICAL

    Sulfonylurea

    (Micronase)

    Meglitinides

    (Prandin)

    Alpha-

    Glycosidase

    Inhibitors

    (Acarbose)

    Biguanides

    (Metformin)

    Thiazolidine-

    diones

    (Actos)

    Thiazolidine-

    diones

    (Actos)

    NUTRI

    CEUTICAL

    Magnesium

    Vanadium

    SolubleFiber

    Complex

    Carbs

    Protein

    Complex

    Carbs

    Protein

    Fiber

    PUFA

    Lipoic Acid

    Linoleic Acid

    PUFA

    Omega-3

    Vanadium

  • 7/31/2019 2010 Metabolic Syndrome

    26/48

    Recommended Nutrients

    EPA 1500-4000 MG

    DHA 1000-2000MG

    Mg 200-400 mg

    Cr 400-1000 ugVd 15-50 mg

    CLA 1000-3000 mg

    Vit E 400-800 U

    Vit C 2-6 gm

    aLA 50-200 mg

    Arg 2 gm

  • 7/31/2019 2010 Metabolic Syndrome

    27/48

    GOOD CARBS

    GLYCEMIC INDEX

    Volunteers blood sugar response to a test food

    containing 50 gm carbohydrate, as compared to

    50 gm pure glucose (3 Tbs)

    HIGH >70%

    MODERATE 55-66%LOW 40-54%

    VERY LOW

  • 7/31/2019 2010 Metabolic Syndrome

    28/48

  • 7/31/2019 2010 Metabolic Syndrome

    29/48

    Foods that Lower I.R.

    Rice (esp. high amylose starch)

    Soluble Fiber (slows glucose absorption)

    Vegetable Protein (modulate GLUT-4transport)

    Complex CHO (slowly digested, prevents

    rapid change in glucose and insulin)

  • 7/31/2019 2010 Metabolic Syndrome

    30/48

    Foods to Avoid

    Refined CHO (Glycemic Index)

    Simple Sugars -High Fructose Corn Syrup

    White bread and flourJuices

    Sugar-containing Soda

    Processed FoodsTrans Fats

    Saturated Fats

  • 7/31/2019 2010 Metabolic Syndrome

    31/48

    GOOD FATS

    Monounsaturated, Mediterranean (olive)

    Omega-3 Fatty Acids (Fish Oils, Flaxseed)Conjugated Linoleic Acid (PPAR agonist,

    acts like TZDs)

    Alpha Lipoic Acid (Antioxidant)

  • 7/31/2019 2010 Metabolic Syndrome

    32/48

    FATS AND HEART DISEASE

    Saturated Fat Diet

    Finland

    US

    Monounsaturated Fat

    Italy Greece

    Low Total Fat

    Japan

  • 7/31/2019 2010 Metabolic Syndrome

    33/48

    Shopping Tips

    AVOID THE CENTER AISLES AT THE

    SUPERMARKET

    SHOP MAINLY IN THE PERIMETER

    AREAS:

    Fresh Produce

    Fruits and Vegetables

    Meats and Eggs

    +/- Frozen Foods

  • 7/31/2019 2010 Metabolic Syndrome

    34/48

  • 7/31/2019 2010 Metabolic Syndrome

    35/48

    UNHEALTHY DIET

    Refined CHO is absorbed rapidly and

    triggers release of excess insulin

    Diminished insulin signal impedes fusion of

    transport channel vesicles with cell

    membrane

    Insulin signal is diminished by

    Phosphotyrosine, TNF alpha, cytokines,NF-kappa, inflammatory substances

  • 7/31/2019 2010 Metabolic Syndrome

    36/48

  • 7/31/2019 2010 Metabolic Syndrome

    37/48

    HEALTHY DIET ANDMICRONUTRIENTS

    Complex CHO more slowly absorbed inintestine appropriate insulin released

    (Soy, Amylose Starch, fiber)

    Insulin signal supported by: Vn, Cr, CLA,Lipoate, Inositol, Mg, Vit E

    Strong insulin signal directs sugar transport

    vesicle to fuse with cell wallCLA binds to nucleus to support gene

    expression

  • 7/31/2019 2010 Metabolic Syndrome

    38/48

    GOALS

    Work closely with PCP

    Approach chronicdiseases by addressingunderlying functional problems

    Formulate a viable program for the

    prevention of disease

  • 7/31/2019 2010 Metabolic Syndrome

    39/48

    CONCLUSIONCorrection of lab values does not

    constitute wellness

    Lifestyle intervention REQUIRESimmediate positive effects & education

    for optimal change and management.

    The healing process needs: support,love, hope & humor

  • 7/31/2019 2010 Metabolic Syndrome

    40/48

    END

  • 7/31/2019 2010 Metabolic Syndrome

    41/48

    CASE PRESENTATIONS

    Metabolic Syndrome

    Insulin ResistanceSyndrome X

    C St d PCOS

  • 7/31/2019 2010 Metabolic Syndrome

    42/48

    Case Study - PCOS

    (Rebecca)31 y.o. Woman with:

    Anxiety

    PMS and MoodinessFatigue

    Amenorrhea

    Sleep Disorder

  • 7/31/2019 2010 Metabolic Syndrome

    43/48

    PCOS (Rebecca)

    October 31Glucose

    FBS 93

    2 hr 112

    Insulin

    Fasting 12

    2 hr 108

    Cholesterol 271

    HDL 39LDL 178

    Triglyceride 269

    Weight 165

    Menses absent

    December 21Glucose

    FBS 91

    2 hr 83

    Insulin

    Fasting 9

    2 hr 17

    Cholesterol 200

    HDL 45LDL 141

    Triglyceride 71

    Weight 153

    Menses regular

    C St d PMS F ti

  • 7/31/2019 2010 Metabolic Syndrome

    44/48

    Case Study PMS, Fatigue

    (Martha)54 y.o. Woman with:

    Anxiety

    Irritable Bowel SymptomsAdrenal Fatigue

    Fibromyalgia

    No weight loss with low fat diet, exercise

  • 7/31/2019 2010 Metabolic Syndrome

    45/48

    Fatigue, FMA (Martha)

    November 8

    Glucose

    FBS 114

    2 hr 209

    Insulin

    Fasting 9

    2 hr 87

    Cholesterol 204

    HDL 77LDL 111

    Triglyceride 78

    Weight 189

    TSH 3.94 (2/13/02)

    February 21

    Glucose

    FBS 104

    2 hr 92

    Insulin

    Fasting 7

    2 hr 25

    Cholesterol

    HDL 70LDL 97

    Triglyceride 84

    Weight 169

  • 7/31/2019 2010 Metabolic Syndrome

    46/48

  • 7/31/2019 2010 Metabolic Syndrome

    47/48

    PHARMACEUTICAL

    SIDE EFFECTSSU - hypoglycemia, weight gain,

    hyperinsulinemia

    Non-SU Secretagogues - same, plus3/day dosing

    Biguanides - GI upset, lactic acidosis

    a-Glucosidase Inhib - GI upset, 3/daydose

    Thiazolidinediones - LFT, weight gain,

    edema, slow onset of action

  • 7/31/2019 2010 Metabolic Syndrome

    48/48

    METABOLIC SYMPTOMS

    AND SYNDROMESSymptoms:Weakness/Fatigue

    Muscle Pain

    Diarrhea/ConstipationStomach Irritation

    Sleep Problems

    Allergy Symptoms

    Inability to Lose Wt

    Immune Problems

    Hypoglycemia

    Syndromes:

    Chronic Fatigue

    FibromyalgiaIrritable Bowel

    Syndrome

    SomatizationPMS/PCOS

    Mood Disorders

    Chronic Yeast